Bayesian Methods for Evidence Synthesis in Cost-Effectiveness Analysis
Top Cited Papers
- 1 January 2006
- journal article
- review article
- Published by Springer Science and Business Media LLC in PharmacoEconomics
- Vol. 24 (1), 1-19
- https://doi.org/10.2165/00019053-200624010-00001
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Management of non-ST-elevation acute coronary syndromes: how cost-effective are glycoprotein IIb/IIIA antagonists in the UK National Health Service?International Journal of Cardiology, 2005
- Combination of direct and indirect evidence in mixed treatment comparisonsStatistics in Medicine, 2004
- Clinical efficacy of antiretroviral combination therapy based on protease inhibitors or non-nucleoside analogue reverse transcriptase inhibitors: indirect comparison of controlled trialsBMJ, 2004
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trialsJAMA, 1995
- Random Effects Models for Combining Results from Controlled and Uncontrolled Studies in a Meta-AnalysisJournal of the American Statistical Association, 1994
- Cross-design Synthesis:A New Form of Meta-analysis for Combining Results from Randomized Clinical Trials and Medical-practice DatabasesInternational Journal of Technology Assessment in Health Care, 1993
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986
- Probabilistic Analysis of Decision Trees Using Monte Carlo SimulationMedical Decision Making, 1986
- Probabilistic Sensitivity Analysis Using Monte Carlo SimulationMedical Decision Making, 1985